Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

A novel T-cell inhibitor has been approved for the treatment of rheumatoid arthritis. Abatacept is the first selective modulator of a costimulatory signal involved in T-cell activation (costimulatory blocker).

Abatacept Infusion (Orencia®)